Status:
UNKNOWN
Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
SARS-CoV-2 infection was identified as responsible for several cases of pneumonia and acute respiratory distress syndromes described in Wuhan, Hubei Province, China in December 2019. A global epidemic...
Detailed Description
Spectroscopy is the discipline of studying the interactions between light and matter, in order to perform analyzes unmatched in terms of the speed of data acquisition. Depending on the spectral ranges...
Eligibility Criteria
Inclusion
- Patient aged ≥ 18 years
- Patient presenting to the GhPSJ for a consultation or hospitalization and for whom a PCR test for SARS-CoV-2 is prescribed as part of his care
- French-speaking patient.
Exclusion
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under legal protection
- Patient objecting to the use of their data for this research.
Key Trial Info
Start Date :
August 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
712 Patients enrolled
Trial Details
Trial ID
NCT04786197
Start Date
August 10 2021
End Date
December 31 2023
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, Île-de-France Region, France, 75014